Bettzy Stephen

12PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsClinical pharmacology and therapeuticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 03, 2026
Bispecific Antibodies in Solid Tumors: Mechanistic Insights, Clinical Advances, and Future Directions.

|Feb 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.

Omar Alhalabi, Mohamed A Gouda, Denái R Milton

|Jan 24, 2025
A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers.

Jibran Ahmed, Filip Janku, Daniel D Karp

|Feb 24, 2024
Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.

Niamh Coleman, Bettzy Stephen, Siqing Fu

|Oct 21, 2023
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.

Anne Knisely, Jibran Ahmed, Bettzy Stephen

|Aug 12, 2023
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma.

Chijioke Nze, Pavlos Msaouel, Mohamed H Derbala

Pageof 2

Frequent Collaborators

8 joint publications

Aung Naing

4 joint publications

Funda Meric-Bernstam

4 joint publications

Siqing Fu

3 joint publications

Vivek Subbiah